Author

N. T. Iqbal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Gori· 2 shared J. E. Bowen· 2 shared J. Geffner· 2 shared K. Ahmed· 2 shared K. R. Sprouse· 2 shared N. M. Franko· 2 shared R. Grifantini· 2 shared A. Bandera· 1 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Gori

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population.

N. T. Iqbal, K. Ahmed, T. Sattar, F. Aziz, R. Hussain

The study examines BCG-induced trained immunity in adults, finding elevated cytokine responses and cross-reactive SARS-CoV-2 antibodies, suggesting potential cross-protection against COVID-19.

bioRxiv · Jan 2, 2024Immunology

SARS-CoV-2 spike conformation determines plasma neutralizing activity

J. E. Bowen, A. C. Walls, A. Joshi, K. R. Sprouse, C. Stewart, M. A. Tortorici, N. M. Franko, J. K. Logue, I. G. Mazzitelli, S. W. Tiles, K. Ahmed, A. Shariq, G. Snell, N. T. Iqbal, J. Geffner, , D. Veesler

This study shows that vaccines encoding a prefusion-stabilized SARS-CoV-2 spike protein induce higher neutralizing antibody titers and better variant cross-neutralization compared to other vaccines or infection.

bioRxiv · Dec 19, 2021 · PreprintImmunology

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

E. Cameroni, C. Saliba, J. E. Bowen, L. E. Rosen, K. Culap, D. Pinto, L. A. VanBlargan, A. De Marco, S. K. Zepeda, J. di Iulio, F. Zatta, H. Kaiser, J. Noack, N. Farhat, N. Czudnochowski, , P

This study shows that Omicron variant's spike protein has enhanced ACE2 binding and reduces neutralizing activity, but some broadly neutralizing antibodies remain effective.

bioRxiv · Dec 12, 2021Immunology